Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter study of different leuprorelin acetate microsphere doses and active comparators for adenomyosis
ChiCTR-IPR-15005971Phase 4Recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Jun 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of leuprolide, avatrombopag and San Jie Zhen Tong in adenomyosis (7 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoints: CA125, FSH and 3 more. Started Jun 2014; status: recruiting.
02
Drugs
leuprolideavatrombopagSan Jie Zhen Tong
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR-IPR-15005971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005971.